Key result
Revascularization linked to improved short-term survival vs medical therapy in moderate-to-large ischemia without prior CAD.
Why the study?
Does revascularization improve short-term survival compared to medical therapy in patients with no prior coronary artery disease and moderate to large inducible ischemia on SPECT?
Does revascularization improve short-term survival compared to medical therapy in patients with no prior coronary artery disease and moderate to large inducible ischemia on SPECT?
Revascularization may offer a short-term survival benefit over medical therapy in patients without prior CAD who demonstrate moderate to large amounts of inducible ischemia on SPECT.
Answers are grounded in this paper and cite their sources.
May support revascularization in moderate-large ischemia on SPECT; leaves open randomized confirmation of short-term survival benefit without prior CAD.
Revascularization compared with MT had greater survival benefit (absolute and relative) in patients with moderate to large amounts of inducible ischemia. These findings have significant consequences for future approaches to post-single photon emission computed tomography patient management if confirmed by prospective evaluations.
No takes yet. Share an insight, caveat, or question.
Hachamovitch et al. (2003) studied this question. Revascularization provided a greater short-term survival benefit compared to medical therapy in patients with moderate to large inducible ischemia and no prior coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: